ICD-10 Code C84.6A | Anaplastic large cell lymphoma, ALK-positive, in remission Symptoms, Diagnosis, Billing

Anaplastic large cell lymphoma (ALCL), ALK-positive, is a subtype of non-Hodgkin lymphoma characterized by the presence of anaplastic lymphoma kinase (ALK) gene rearrangements. This condition is clinically significant due to its aggressive nature and potential for remission with appropriate treatment. The ICD-10 Code C84.6A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track patient outcomes.

What is ICD-10 Code C84.6A for Anaplastic large cell lymphoma, ALK-positive, in remission?

ICD-10 Code C84.6A represents Anaplastic large cell lymphoma, ALK-positive, in remission. This code is used to document patients who have achieved remission from this aggressive lymphoma subtype, which is associated with the ALK gene rearrangement. It is essential for clinical documentation and billing when the patient is no longer exhibiting active disease, allowing for appropriate coding and tracking of treatment outcomes.

ICD-10 Code C84.6A – Clinical Definition and Explanation of Anaplastic large cell lymphoma, ALK-positive, in remission

Anaplastic large cell lymphoma, ALK-positive, is a hematological malignancy that arises from T-cells and is characterized by the presence of ALK gene rearrangements. This condition can lead to significant morbidity if not treated promptly. Remission indicates a reduction or absence of disease symptoms, necessitating ongoing monitoring and follow-up care.

Key Clinical Features:

• Presence of ALK gene rearrangement detected via molecular testing.
• Common symptoms include lymphadenopathy, fever, weight loss, and night sweats.
• Typically affects younger adults and children, with a higher prevalence in males.
• Can present with extranodal involvement, including skin and bone.

ICD-10 Code C84.6A for Anaplastic large cell lymphoma, ALK-positive, in remission – SOAP Notes & Clinical Use

ICD-10 Code C84.6A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers can accurately track patient progress and outcomes.

What Does ICD-10 Code C84.6A for Anaplastic large cell lymphoma, ALK-positive, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C84.6A connects subjective patient reports and objective clinical findings to a formal diagnosis of remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C84.6A – Anaplastic large cell lymphoma, ALK-positive, in remission

Management of Anaplastic large cell lymphoma, ALK-positive, in remission focuses on monitoring for recurrence and managing any residual symptoms. Hospitalization may be required for complications or treatment-related issues.

Antibiotic Therapy:

• Not applicable as this condition is not infectious; however, prophylactic antibiotics may be considered in immunocompromised patients.

Supportive Care:

• Regular follow-up appointments for monitoring.
• Symptom management including pain control and nutritional support.
• Psychosocial support for emotional well-being.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.
• Education on hygiene practices and avoiding sick contacts.

How to Document Symptoms of Anaplastic large cell lymphoma, ALK-positive, in remission (ICD-10 C84.6A) in SOAP Notes

Subjective:

• Patient reports feeling well with no current symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous lymphadenopathy now resolved.

Objective:

• Physical examination shows no palpable lymphadenopathy.
• Vital signs within normal limits.
• Laboratory tests indicate normal blood counts and no evidence of disease.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Anaplastic large cell lymphoma, ALK-positive, in remission (ICD-10 Code C84.6A)

Assessment:

• Anaplastic large cell lymphoma, ALK-positive, in remission (ICD-10 Code C84.6A).
• No current symptoms or signs of active disease.
• Patient is stable with regular follow-up.

Plan:

• Continue regular follow-up every 3-6 months.
• Monitor for any new symptoms or signs of recurrence.
• Educate patient on signs of recurrence and when to seek care.

Treatment & Plan Section for ICD-10 Code C84.6A – Anaplastic large cell lymphoma, ALK-positive, in remission

• Regular follow-up appointments to monitor for recurrence.
• Patient education on potential late effects of treatment.
• Psychosocial support services as needed.
• Routine laboratory tests to assess overall health.

Using ICD-10 Code C84.6A for Anaplastic large cell lymphoma, ALK-positive, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in the Subjective and Objective sections.
• Use C84.6A when the patient is in remission to support appropriate billing.
• Document any ongoing treatment or follow-up plans clearly.
• Align treatment plans with clinical guidelines to justify billing.

Related ICD-10 Codes Often Used with Anaplastic large cell lymphoma, ALK-positive, in remission

ICD-10 Code C84.6A in Medical Billing and Insurance for Anaplastic large cell lymphoma, ALK-positive, in remission

ICD-10 Code C84.6A is crucial for billing purposes, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document the patient's remission status clearly to support claims.
• Use C84.6A in conjunction with treatment codes for comprehensive billing.
• Ensure all relevant clinical information is included in the medical record.

Common CPT Pairings: